Daniel R Chard insider trades: Medifast (MED) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | MED | ↓ Sell | 19,089 | $11.85 | $226K | The Dan and Allyson Family Irrevocable T | Sep 30, 2026 (1d) |
| Jun 13, 2025 | MED | ↑ Buy | 381 | $13.13 | $5K | The Dan and Allyson Family Irrevocable T | Jun 17, 2025 (4d) |
| May 5, 2022 | MED | ↑ Buy | 431 | $183.25 | $79K | The Dan and Allyson Family Irrevocable T | May 11, 2022 (6d) |
| Feb 4, 2022 | MED | ↑ Buy | 690 | $186.40 | $129K | The Dan and Allyson Family Irrevocable T | Apr 21, 2022 (76d) |
| Jun 17, 2021 | MED | ↓ Sell10b5-1 | 6,365 | $263.55 | $1.7M | Direct | Jun 21, 2021 (4d) |
| Jun 16, 2021 | MED | ↓ Sell10b5-1 | 13,520 | $278.00 | $3.8M | Direct | Jun 17, 2021 (1d) |
| Jun 14, 2021 | MED | ↓ Sell10b5-1 | 15,115 | $285.21 | $4.3M | Direct | Jun 15, 2021 (1d) |
| Nov 8, 2018 | MED | ↑ Buy | 975 | $153.28 | $149K | Direct | Nov 13, 2018 (5d) |
| Jul 6, 2015 | NUS | ↓ Sell | 17,500 | $46.67 | $817K | Direct | Jul 8, 2015 (2d) |
| Dec 2, 2013 | NUS | ↓ Sell | 72,500 | $125.39 | $9.1M | Direct | Dec 4, 2013 (2d) |
| Feb 13, 2013 | NUS | ↓ Sell | 50,000 | $42.71 | $2.1M | Direct | Feb 14, 2013 (1d) |
| Jun 21, 2011 | NUS | ↓ Sell | 10,000 | $38.00 | $380K | Direct | Jun 24, 2011 (3d) |
| Jun 16, 2011 | NUS | ↓ Sell | 25,000 | $36.55 | $914K | Direct | Jun 20, 2011 (4d) |
| Jun 13, 2011 | NUS | ↓ Sell | 38,750 | $35.08 | $1.4M | Direct | Jun 14, 2011 (1d) |
| May 2, 2011 | NUS | ↓ Sell | 5,000 | $32.11 | $161K | Direct | May 3, 2011 (1d) |
| Feb 1, 2011 | NUS | ↓ Sell10b5-1 | 10,000 | $30.05 | $301K | Direct | Feb 3, 2011 (2d) |
| Nov 1, 2010 | NUS | ↓ Sell10b5-1 | 30,000 | $30.12 | $904K | Direct | Nov 3, 2010 (2d) |
| Oct 21, 2010 | NUS | ↓ Sell10b5-1 | 2,706 | $30.16 | $82K | Direct | Oct 22, 2010 (1d) |
| Oct 6, 2010 | NUS | ↓ Sell10b5-1 | 30,000 | $29.50 | $885K | Direct | Oct 7, 2010 (1d) |
| Jul 27, 2010 | NUS | ↓ Sell | 11,628 | $29.87 | $347K | Direct | Aug 3, 2010 (7d) |
| Mar 8, 2010 | NUS | ↓ Sell10b5-1 | 58,058 | $29.88 | $1.7M | Direct | Mar 10, 2010 (2d) |
| Jan 6, 2010 | NUS | ↓ Sell | 5,208 | $27.21 | $142K | Direct | Jan 7, 2010 (1d) |
| Nov 19, 2007 | NUS | ↑ Buy | 1,450 | $17.63 | $26K | Direct | Nov 26, 2007 (7d) |
| Aug 31, 2005 | NUS | ↓ Sell | 2,094 | $21.22 | $44K | Direct | Sep 6, 2005 (6d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MED insiders
Open-market trades in the last 12 months
About Daniel R Chard's insider trades
Daniel R Chard is a director at Medifast (MED). Since Aug 31, 2005, Daniel has reported 5 open-market purchases worth $388K and 19 sales worth $29.3M on SEC Form 4. In the last 12 months: 1 sale ($226K).
8 sales (47% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (37 filings), shares withheld for taxes (23 filings), option exercises (18 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.